Measurement of changes in forehead height after endoscopic forehead lift by Jae Min Chung, Won Ki Kang, Jeong Su Shim

Get full text

Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer by Youjin Kim, Seung Tae Kim, Jeeyun Lee, Won Ki Kang, Kyoung-Mee Kim, Se Hoon Park

Get full text

Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer by You Jeong Heo, So Young Kang, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim

Get full text

Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer by Minkyue Shin, Soomin Ahn, Jaeyun Jung, Sujin Hyung, Kyoung‐Mee Kim, Seung Tae Kim, Won Ki Kang, Jeeyun Lee

Get full text

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial by Seung Tae Kim, Jason K. Sa, Sung Yong Oh, Kyung Kim, Jung Yong Hong, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee

Get full text

The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy by Min-Kyue Shin, Min-Gew Choi, Seung-Tae Kim, Won-Ki Kang, Tae-Sung Sohn, Ji-Yeong An, Joon-Ho Lee, Jee-Yun Lee

Get full text

Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract by Ji Eun Uhm, Ho Yeong Lim, Won Seog Kim, Han Yong Choi, Hyun Moo Lee, Byeong-Bae Park, Keunchil Park, Won Ki Kang

Get full text

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer by Jinchul Kim, Binnari Kim, So Young Kang, You Jeong Heo, Se Hoon Park, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim

Get full text

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers by Hye Ryeon Kim, Hye Ryeon Kim, Soomin Ahn, Hyunji Jo, Hongsik Kim, Joohyun Hong, Jeeyun Lee, Ho-Yeong Lim, Won Ki Kang, Seung Tae Kim

Get full text

Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody by Nalee Kim, Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Seung Tae Kim, Jung Yong Hong, Won Ki Kang, Woo Kyoung Jeong, Kyoung-Mee Kim

Get full text

The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer by Su Jin Lee, Jung Eun Kim, Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Won Ki Kang, Young Suk Park, Ho Yeong Lim

Get full text

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2–Amplified Gastric Cancer Patient–Derived Cell Model by Jiryeon Jang, Hee Kyung Kim, Heejin Bang, Seung Tae Kim, Sun Young Kim, Se Hoon Park, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim

Get full text

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors by Hana Kim, Jung Yong Hong, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim

Get full text

288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors by Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Do-Youn Oh, Jeeyun Lee, Won Ki Kang, Yeon Hee Park, Ji Hye Lee, Yun Jeong Song, Young Suk Park

High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. by Jeeyun Lee, Paul van Hummelen, Christina Go, Emanuele Palescandolo, Jiryeon Jang, Ha Young Park, So Young Kang, Joon Oh Park, Won Ki Kang, Laura MacConaill, Kyoung-Mee Kim

Get full text

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study by Dohee Kwon, Binnari Kim, Hyeong Chan Shin, Eun Ji Kim, Sang Yun Ha, Kee-Taek Jang, Seung Tae Kim, Jeeyun Lee, Won Ki Kang, Joon Oh Park, Kyoung-Mee Kim

Get full text

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer by Jihoon Ko, Jaeyun Jung, Seung Tae Kim, Jung Yong Hong, Sehhoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Soomin Ahn, Kyoung-Mee Kim, Won Ki Kang, Jeeyun Lee

Get full text

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment by Min-Sang Lee, Hee Jin Cho, Jung Yong Hong, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seung Tae Kim

Get full text

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer by Seung Tae Kim, Kee-Taek Jang, Jeeyun Lee, Heung-Moon Jang, Hye-Jin Choi, Hye-Lim Jang, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park

Get full text

Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors by Eunhae Shin, Dong Hui Lim, Jisang Han, Do-Hyun Nam, Keunchil Park, Myung-Ju Ahn, Won Ki Kang, Jeeyun Lee, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Hyun Ae Jung, Tae-Young Chung

Get full text